Phase II study of oral temozolomide (TMZ) in children with progressive low-grade gliomas (LGG)
Publication
, Conference
Gururangan, S; Allen, JC; Phillips, PC; Dillard, E; Friedman, HS
Published in: NEURO-ONCOLOGY
October 1, 2004
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2004
Volume
6
Issue
4
Start / End Page
457 / 457
Location
Boston, MA
Publisher
DUKE UNIV PRESS
Conference Name
11th International Symposium on Pediatric Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gururangan, S., Allen, J. C., Phillips, P. C., Dillard, E., & Friedman, H. S. (2004). Phase II study of oral temozolomide (TMZ) in children with progressive low-grade gliomas (LGG). In NEURO-ONCOLOGY (Vol. 6, pp. 457–457). Boston, MA: DUKE UNIV PRESS.
Gururangan, S., J. C. Allen, P. C. Phillips, E. Dillard, and H. S. Friedman. “Phase II study of oral temozolomide (TMZ) in children with progressive low-grade gliomas (LGG).” In NEURO-ONCOLOGY, 6:457–457. DUKE UNIV PRESS, 2004.
Gururangan S, Allen JC, Phillips PC, Dillard E, Friedman HS. Phase II study of oral temozolomide (TMZ) in children with progressive low-grade gliomas (LGG). In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 457–457.
Gururangan, S., et al. “Phase II study of oral temozolomide (TMZ) in children with progressive low-grade gliomas (LGG).” NEURO-ONCOLOGY, vol. 6, no. 4, DUKE UNIV PRESS, 2004, pp. 457–457.
Gururangan S, Allen JC, Phillips PC, Dillard E, Friedman HS. Phase II study of oral temozolomide (TMZ) in children with progressive low-grade gliomas (LGG). NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 457–457.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2004
Volume
6
Issue
4
Start / End Page
457 / 457
Location
Boston, MA
Publisher
DUKE UNIV PRESS
Conference Name
11th International Symposium on Pediatric Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences